24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Investing
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
08:50
Israel strikes Iran; explosions heard in Isfahan
20:16
Cyber decacorn Wiz in advanced negotiation to acquire Lacework for $150-200 million
19:47
Google lays off 28 employees for protesting against Israeli cloud contract
19:29
Full list of Israeli high-tech funding rounds in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
Cyber decacorn Wiz in advanced negotiation to acquire Lacework for $150-200 million
2
Israeli Billionaire Hires Black Cube to Spy on Former Partner Company Vale
3
Google employees arrested following protest over Israel ties at executive’s office
4
The price of failure: Dutch company's chip monopoly born from a bad bet by Intel
5
Cyber unicorn Armis acquiring Silk Security for $150 million
More news
Investing
11 stories about Investing
Unicorn School Lessons 7 and 8: Equity trumps salaries and the path to $100 billion companies
25.12.20
|
Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
Unicorn School Lesson 6: Making an exit: when you fly too fast, the plane shakes
24.12.20
|
Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
Unicorn School Lesson 5: Don’t turn down money that hits you in the face
23.12.20
|
Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
Unicorn School Lessons 3 and 4: Stick to a business model and don't indulge in frivolous luxuries
22.12.20
|
Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leaped beyond $2 billion offer insights and tips for building unicorns
“We haven't seen this type of divorce from reality since the dot-com boom”
21.12.20
|
CTech
Senior Managing Director and Global Head of Blackstone's Growth Equity Business, Jon Korngold, doesn’t believe we are in a stock market bubble but says there is definitely a relaxing of some of the discipline we have come to see in the public markets in recent years
Unicorn School Lesson 1: $100 billion egos and the mentality of a watermelon
20.12.20
|
Sophie Shulman
The founders of Tipalti, Gong, and Next Insurance, whose companies’ valuations have leapt beyond $2 billion offer insights and tips for building unicorns
“Israeli high tech has found a home at the Tel Aviv Stock Exchange,” says Chairwoman of the Israel Securities Authority
16.12.20
|
Hezi Sternlicht
“Capital markets are enjoying a renaissance period,” Anat Guetta said during Calcalist’s investment conference. “High tech has returned to Israel. It’s no longer aiming to raise money in foreign markets”
How to create a stable of unicorns: J-Ventures panel debates investments in the biggest tech companies
16.12.20
|
CTech
Michael Rolnick, Merav Weinryb, Jake Sein, and Brett Rokhind discuss their investment strategies at J-Ventures’ annual Investors Conference
How will engineering look in the future and what is going on under Jerusalem's hills?
05.08.20
|
CTech
CTech Daily Roundup: Lawsuit claims Harman dodged millions of dollars in payments after 2016 TowerSec acquisition
$100 million investment in Israel is just the beginning, says Shengjing Peakview Capital exec
16.07.20
|
Allon Sinai
Sherrie Wang, Managing Partner at one of China's largest global fund of funds, is optimistic regarding China-Israel economic relations
Activist Investor Jana Partners Takes Stake in Teva, Report Says
23.01.18
|
Lilach Baumer
The firm has taken a position in the troubled drugmaker during the fourth quarter of 2017, believing CEO Kåre Schultz's cost-cutting measures could turn the company around, according to a Bloomberg report
Previous Articles
Please ensure Javascript is enabled for purposes of
website accessibility